Baltimore biotech raises $1.6M to put toward wound healing solution

georgedavis2jb750xx4162-2341-0-217

Authored by: Sarah Gantz, Baltimore Business Journal

Baltimore startup Gemstone Biotherapeutics has raised $1.6 million as it races to bring to market a synthetic material for healing wounds.

The financing round was led by founding investor Gamma 3 LLC in Baltimore. The new funding brings Gemstone’s total seed funding to $2.45 million.

Read more at Baltimore Business Journal